Robert H. Levin
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Steroid Chemistry and Biochemistry, Calibration and Measurement Techniques, Pharmaceutical studies and practices
Most-Cited Works
- → Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19(2020)1,364 cited
- → Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera(2021)1,141 cited
- → Antibody evasion by the P.1 strain of SARS-CoV-2(2021)655 cited
- → Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera(2021)529 cited
- → The antigenic anatomy of SARS-CoV-2 receptor binding domain(2021)431 cited
- → Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison(2020)403 cited
- → The Effectiveness of Combinations of Antileukemic Agents in Inducing and Maintaining Remission in Children with Acute Leukemia